Treace Medical Concepts reports declining revenue due to increased competition.

• Treace Medical Concepts reports decline in revenue • Primary product Lapiplasty faces increased competition • Demand and utilization of Lapiplasty impacted • Company accelerates plans for alternative product • Securities class action lawsuit filed • Shareholders encouraged to contact Gross Law Firm • Lead plaintiff appointment not required for recovery • Treace Medical Concepts, Inc. (NASDAQ: TMCI) • Class period: May 8, 2023 to May 7, 2024

Treace Medical Concepts, Inc. (TMCI), a medical device company listed on NASDAQ, is facing a securities fraud lawsuit. The Rosen Law Firm, a global investor rights law firm, has announced that investors who purchased TMCI securities between May 8, 2023, and May 7, 2024, may be eligible to join a class action lawsuit.

The lawsuit alleges that during the class period, TMCI made false and/or misleading statements and failed to disclose significant information. These include:

1. Increased competition impacting the demand and utilization of their primary product, the Lapiplasty 3D Bunion Correction System.
2. Revenue decline as a result of the aforementioned competition, leading to the acceleration of plans for an alternative product.
3. Materially misleading statements about the company's business, operations, and prospects.

Investors who suffered losses in excess of $100,000 are encouraged to contact the Rosen Law Firm for more information. The lead plaintiff deadline is June 10, 2025. It is important to note that being a lead plaintiff is not a requirement for recovery. Investors can remain absent class members and still participate in the class action [1].

The Rosen Law Firm has a proven track record in securities class actions, having recovered hundreds of millions of dollars for investors. The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has been ranked in the top 4 each year since 2013 [1].

Investors are encouraged to seek qualified counsel to protect their rights. The Rosen Law Firm can be contacted via their website at [https://rosenlegal.com](https://rosenlegal.com) or by phone at 866-767-3653.

References:

[1] https://www.globenewswire.com/news-release/2025/06/08/3095582/673/en/TMCI-FINAL-DEADLINE-ROSEN-NATIONAL-TRIAL-COUNSEL-Encourages-Treace-Medical-Concepts-Inc-Investors-with-Losses-in-Excess-of-100K-to-Secure-Counsel-Before-Important-June-10-Deadline-.html